We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close


'IV Cocktail' Ads Stir FTC To Prioritize Health Enforcement

Law360 (September 25, 2018, 9:14 PM EDT) -- The Federal Trade Commission last week required a company to stop marketing its intravenous therapy "cocktails" as a treatment for serious diseases without scientific proof, a first-of-its-kind action that signals the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.